Bloomage Biotechnology Corp Ltd
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature nam… Read more
Market Cap & Net Worth: Bloomage Biotechnology Corp Ltd (688363)
Bloomage Biotechnology Corp Ltd (SHG:688363) has a market capitalization of $2.96 Billion (CN¥21.72 Billion) as of March 18, 2026. Listed on the SHG stock exchange, this China-based company holds position #6766 globally and #1071 in its home market, demonstrating a 2.55% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bloomage Biotechnology Corp Ltd's stock price CN¥45.10 by its total outstanding shares 481678242 (481.68 Million).
Bloomage Biotechnology Corp Ltd Market Cap History: 2019 to 2026
Bloomage Biotechnology Corp Ltd's market capitalization history from 2019 to 2026. Data shows change from $5.40 Billion to $2.96 Billion (-9.30% CAGR).
Bloomage Biotechnology Corp Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bloomage Biotechnology Corp Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.62x
Bloomage Biotechnology Corp Ltd's market cap is 0.62 times its annual revenue
0.59x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
19.23x
Bloomage Biotechnology Corp Ltd's market cap is 19.23 times its annual earnings
710.94x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $5.40 Billion | $1.89 Billion | $585.61 Million | 2.86x | 9.22x |
| 2020 | $9.50 Billion | $2.63 Billion | $645.84 Million | 3.61x | 14.71x |
| 2021 | $10.09 Billion | $4.95 Billion | $782.33 Million | 2.04x | 12.89x |
| 2022 | $8.82 Billion | $6.36 Billion | $970.92 Million | 1.39x | 9.09x |
| 2023 | $4.39 Billion | $6.08 Billion | $592.56 Million | 0.72x | 7.42x |
| 2024 | $3.35 Billion | $5.37 Billion | $174.27 Million | 0.62x | 19.23x |
Competitor Companies of 688363 by Market Capitalization
Companies near Bloomage Biotechnology Corp Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Bloomage Biotechnology Corp Ltd by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #71 globally with a market cap of $210.18 Billion USD.
- L'Air Liquide S.A (PINK:AIQUF): Ranked #182 globally with a market cap of $107.70 Billion USD.
- Air Liquide SA (PA:AI): Ranked #200 globally with a market cap of $99.38 Billion USD ( €96.82 Billion EUR).
- Ecolab Inc (NYSE:ECL): Ranked #266 globally with a market cap of $77.81 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #71 | Linde plc Ordinary Shares | NASDAQ:LIN | $210.18 Billion | $494.05 |
| #182 | L'Air Liquide S.A | PINK:AIQUF | $107.70 Billion | $187.03 |
| #200 | Air Liquide SA | PA:AI | $99.38 Billion | €172.22 |
| #266 | Ecolab Inc | NYSE:ECL | $77.81 Billion | $272.59 |
Bloomage Biotechnology Corp Ltd Historical Marketcap From 2019 to 2026
Between 2019 and today, Bloomage Biotechnology Corp Ltd's market cap moved from $5.40 Billion to $ 2.96 Billion, with a yearly change of -9.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥2.96 Billion | +3.25% |
| 2025 | CN¥2.87 Billion | -14.42% |
| 2024 | CN¥3.35 Billion | -23.74% |
| 2023 | CN¥4.39 Billion | -50.19% |
| 2022 | CN¥8.82 Billion | -12.55% |
| 2021 | CN¥10.09 Billion | +6.20% |
| 2020 | CN¥9.50 Billion | +76.03% |
| 2019 | CN¥5.40 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Bloomage Biotechnology Corp Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.96 Billion USD |
| MoneyControl | $2.96 Billion USD |
| MarketWatch | $2.96 Billion USD |
| marketcap.company | $2.96 Billion USD |
| Reuters | $2.96 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.